Pemetrexed-Resistant Non-Small Cell Lung Cancer Cell Lines Have Novel Drug-Resistant Mechanisms

被引：0
|
作者：
Tanino, R. [1 ]
Tsubata, Y. [2 ]
Harashima, N. [3 ]
Harada, M. [4 ]
Isobe, T. [2 ]
机构：
[1] Shimane Univ, Div Med Oncol & Resp Med, Dept Internal Med, Izumo, Shimane, Japan
[2] Shimane Univ, Div Med Oncol & Resp Med, Izumo, Shimane, Japan
[3] Univ Ryukyus, Fac Med, Lab Biometab Chem, Sch Hlth Sci, Nishihara, Okinawa, Japan
[4] Shimane Univ, Fac Med, Dept Immunol, Izumo, Shimane, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
pemetrexed; drug resistance; EGFR-TKI;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.02-069
引用
收藏
页码：S1949 / S1949
页数：1
相关论文
共 50 条
  • [21] Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
    Jung, M-J
    Rho, J-K
    Kim, Y-M
    Jung, J. E.
    Jin, Y. B.
    Ko, Y-G
    Lee, J-S
    Lee, S-J
    Lee, J. C.
    Park, M-J
    ONCOGENE, 2013, 32 (02) : 209 - 221
  • [22] Rational Computational Design of Fourth-Generation EGFR Inhibitors to Combat Drug-Resistant Non-Small Cell Lung Cancer
    Park, Hwangseo
    Jung, Hoi-Yun
    Kim, Kewon
    Kim, Myojeong
    Hong, Sungwoo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 23
  • [23] Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
    M-J Jung
    J-K Rho
    Y-M Kim
    J E Jung
    Y B Jin
    Y-G Ko
    J-S Lee
    S-J Lee
    J C Lee
    M-J Park
    Oncogene, 2013, 32 : 209 - 221
  • [24] Establishment of a human non-small cell lung cancer cell line resistant to gefitinib
    Koizumi, F
    Shimoyama, T
    Taguchi, F
    Saijo, N
    Nishio, K
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (01) : 36 - 44
  • [25] Stratification of non-small cell lung adenocarcinoma patients with EGFR actionable mutations based on drug-resistant stem cell genes
    Xie, Xiaohong
    Li, Lifeng
    Xie, Liang
    Liu, Zhentian
    Zhang, Guoliang
    Gao, Xuan
    Peng, Wenying
    Deng, Haiyi
    Yang, Yilin
    Yang, Meiling
    Chang, Lianpeng
    Yi, Xin
    Xia, Xuefeng
    He, Zhiyi
    Zhou, Chengzhi
    ISCIENCE, 2023, 26 (06)
  • [26] The use of pemetrexed in advanced non-small cell lung cancer
    Ng, C.
    Harris, M. A.
    Burt, P. A.
    Sheikh, H. S.
    Lee, L.
    Blackhall, F. H.
    Summers, Y.
    Taylor, P.
    Coote, J.
    Chittalia, A.
    Califano, R.
    Bayman, N.
    LUNG CANCER, 2014, 83 : S12 - S12
  • [27] Pemetrexed in second line of non-small cell lung cancer
    Earata, Fernando
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2008, 14 : S21 - S26
  • [28] Pemetrexed for treatment of advanced non-small cell lung cancer
    Fossella, FV
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 100 - 105
  • [29] Reversible Drug Resistance Mechanisms in Non-small Cell Lung Cancer
    Haga, Yuya
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2022, 142 (12): : 1321 - 1326
  • [30] Synergistic effects of pemetrexed and amrubicin in non-small cell lung cancer cell lines: Potential for combination therapy
    Hatakeyama, Yukihisa
    Kobayashi, Kazuyuki
    Nagano, Tatsuya
    Tamura, Daisuke
    Yamamoto, Masatsugu
    Tachihara, Motoko
    Kotani, Yoshikazu
    Nishimura, Yoshihiro
    CANCER LETTERS, 2014, 343 (01) : 74 - 79
12345